Sumatriptan Succinate
Overview
Sumatriptan Succinate is a selective serotonin receptor agonist used primarily in the treatment of migraine attacks. It functions by narrowing blood vessels in the brain, stopping pain signals, and affecting other substances that can trigger migraine symptoms.
API suppliers (8)
Suppliers of Sumatriptan Succinate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 8 suppliers.
7 of 8 hold a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance
- Natco PharmaIndia1 active DMF GMP on record
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- QUIMICA SINTETICA SASpain1 active DMF GMP on record
- MOEHS IBERICA SLSpain1 active DMF GMP on record
- Natco PharmaIndiaCEP GMP on record
- ASYMCHEM LIFE SCIENCE TIANJIN CO LTDChina
- SMS Pharmaceuticals limitedIndia GMP on record
Therapeutic areas
Do you supply Sumatriptan Succinate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.